Cartesian Therapeutics (RNAC) Other Non Operating Income (2015 - 2026)
Cartesian Therapeutics (RNAC) posted quarterly Other Non Operating Income of -$3000.0 for Q1 2026, down 100.04% quarter-over-quarter from $7.5 million in Q4 2024.
Cartesian Therapeutics (RNAC) Other Non Operating Income (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has reported Other Non Operating Income for 11 consecutive years, with -$3000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non Operating Income changed N/A year-over-year to -$3000.0; the TTM figure through Mar 2026 stood at -$3000.0 (down 100.04% YoY), while the FY2024 annual figure was $606000.0, up 100.41% from the prior year.
- Other Non Operating Income slipped to -$3000.0 in Q1 2026 per RNAC's latest filing, from $7.5 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $7.5 million in Q4 2024 and bottomed at -$149.6 million in Q4 2023.
- Historically, Other Non Operating Income has averaged -$12.4 million across 4 years, with a median of $12000.0 in 2022.
- Annual changes were most pronounced in 2023 — Other Non Operating Income plunged 84441.81% — and 2024, when it surged 8433.33%.
- Cartesian Therapeutics' Other Non Operating Income stood at -$177000.0 in 2022, then slumped by 84441.81% to -$149.6 million in 2023, then surged by 105.01% to $7.5 million in 2024, then slumped by 100.04% to -$3000.0 in 2026.
- Business Quant data shows RNAC's Other Non Operating Income at -$3000.0 in Q1 2026, $7.5 million in Q4 2024, and $250000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Cartesian Therapeutics | 265.54 Mn | 265.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 126,000.00 |
| Mar 31, 2026 | -3,000.00 |
| Dec 31, 2024 | 7.50 Mn |
| Sep 30, 2024 | 250,000.00 |
| Jun 30, 2024 | 292,000.00 |
| Mar 31, 2024 | -6.89 Mn |
| Dec 31, 2023 | -149.64 Mn |
| Sep 30, 2023 | -3,000.00 |
| Jun 30, 2023 | 23,000.00 |
| Mar 31, 2023 | 255,000.00 |
| Dec 31, 2022 | -177,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Mar 31, 2022 | 154,000.00 |
| Dec 31, 2021 | 515,000.00 |
| Sep 30, 2021 | -500,000.00 |
| Jun 30, 2021 | -14,000.00 |
| Dec 31, 2020 | 556,000.00 |
| Sep 30, 2020 | -500,000.00 |
| Jun 30, 2020 | 59,000.00 |
| Mar 31, 2020 | 82,000.00 |